Sincalide

HCID 9833444
노트반응
부분 구조 검색유사 구조 찾기

기본 정보

CAS
25126-32-3
표준 SMILES
CSCC[C@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
InChIKey
IZTQOLKUZKXIRV-YRVFCXMDSA-N
분자식
C49H62N10O16S3
평균 분자량
1,143.3 g/mol
단동위원소 질량
1,142.35073945

이름 및 식별자

우선 이름
Sincalide
IUPAC
(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1-oxo-3-(4-sulfooxyphenyl)propan-2-yl]amino]-4-oxobutanoic acid
영어명
Sincalide
분자식
C49H62N10O16S3
분자량
1143.27

이름 및 동의어

Sincalide25126-32-3CCK-8KinevacSincalidaCCK-8SSincalidumSyncalideSQ 19844cholecystokinin C-terminal octapeptideDTXSID7048617CCK C-terminal octapeptide
이름 더 보기
Sincalide AcetateSincalidabs50003Sinkalite
SQ-19844M03GIQ7Z6PH-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2Caerulein, 1-de(5-oxo-L-proline)-2-de-L-glutamine-5-L-methionine-Cholecystokinin octapeptideDTXCID4028543L-alpha-Aspartyl-O-sulfo-L-tyrosyl-L-methionylglycyl-L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamideL-Aspartyl-L-tyrosyl-L-methionylglycyl-L-tryptophyl-L-methionyl-L-aspartylphenyl-L-alaninamide hydrogen sulfate (ester)

데이터베이스 식별자

CAS
25126-32-3
PubChem CID
9833444
DTXSID
DTXSID7048617
ChEMBL
CHEMBL1121
ChEBI
CHEBI:135946
UNII
M03GIQ7Z6P
EC Number
246-639-0
Nikkaji
J236.060H

물성

구조 계산 물성

XLogP
-2.6
극성 표면적
486 Ų
수소 결합 공여자 수
13
수소 결합 수용자 수
19
회전 가능 결합 수
33
무거운 원자 수
78

물리화학적 성질

녹는점
193 °C · >193°C (dec.)
밀도
1.44 · 1.440±0.06 g/cm3(Predicted)
저장 조건
-20 °C · -20°C
용해도
0.05 M · 0.05 M 수산화암모늄: 1 mg/mL, 투명, 무색
물리적 상태
가루
산도 계수 (pKa)
-4.17 · -4.17±0.18(Predicted)

안전 및 규제

독성 정보

Drug Induced Liver Injury · 6건

Drug Induced Liver Injury Rank (DILIrank 2.0)

Sincalide

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation · 1건

◉ Summary of Use during Lactation；Sincalide is a synthetic octapeptide analogue of cholecystokinin. Because sincalide has a molecular weight of 1143 Da, the amount in milk is likely to be low and oral absorption by the infant is unlikely because it is probably partially destroyed in the infant's gastrointestinal tract and poorly absorbed orally. The serum half-life of sincalide is less than 2 minutes, indicating that withholding breastfeeding for 10 minutes after a dose should ensure that the infant is not exposed to the drug.；◉ Effects in Breastfed Infants；Relevant published information was not found as of the revision date.；◉ Effects on Lactation and Breastmilk；Relevant published information was not found as of the revision date.

안전 데이터

wgk
3
HS 번호
2933998090
safety_code
22-24/25
F 고인화성물질
8-10-21
스토리지 클래스
11 - Combustible Solids

화학 및 산업

약리 정보

ATC Code · 2건

V - Various；V04 - Diagnostic agents；V04C - Other diagnostic agents；V04CC - Tests for bile duct patency；V04CC03 - Sincalide

QV - Various；QV04 - Diagnostic agents；QV04C - Other diagnostic agents；QV04CC - Tests for bile duct patency；QV04CC03 - Sincalide

Protein BindingLimited information is available on the protein binding of sincalide.
Pharmacodynamics · 1건

Following an intravenous (bolus) injection of 0.02 mcg/kg of sincalide, maximal contraction of the gallbladder occurred in 5 to 15 minutes. Sincalide reduced gallbladder radiographic size by at least 40%, generally considered satisfactory contraction.

Mechanism of Action · 1건

When injected intravenously, sincalide produces a substantial reduction in gallbladder size by causing this organ to contract. The evacuation of bile that results is similar to that which occurs physiologically in response to endogenous cholecystokinin. Like cholecystokinin, sincalide stimulates pancreatic secretion; concurrent administration with secretin increases both the volume of pancreatic secretion and the output of bicarbonate and protein (enzymes) by the gland. This combined effect of secretin and sincalide permits the assessment of specific pancreatic function through measurement and analysis of the duodenal aspirate.

Biological Half-LifeLimited information is available on the half-life of sincalide.
Metabolism/MetabolitesLimited information is available on the metabolism of sincalide.
응용 분야 · 2건

용도Sincalide is used in the biological studies in the preparation of opioid receptors agonistic and CCK receptor antagonistic activity.

일반 설명It was thought originally that cholecystokinin and pancreozyminwere two different hormones. Cholecystokinin wasthought to be responsible for contraction of the gallbladder,whereas pancreozymin was believed to induce secretion ofpancreatic enzymes. It is now clear that both actions arecaused by a single 33-residue polypeptide, referred to ascholecystokinin–pancreozymin (CCK-PZ). CCK-PZ is secretedin the blood in response to the presence of food in theduodenum, especially long-chain fatty acids. The fiveCOOH-terminal amino acid residues are identical with thosein gastrin. The COOH-terminal octapeptide retains full activityof the parent hormone.

상·하류 제품 정보

상류 원료

공급사100 곳

北京华美互利生物化工010-56205725 · [email protected]
上海康朗生物科技有限公司021-61998208 18217752821 · [email protected]
合肥翰刚医药科技有限公司+8618062405514 · [email protected]
上海优宁维生物科技股份有限公司15921930842 15921930842 · [email protected]
Hangzhou Go Top Peptide Biotech0571-88211921 · [email protected]

관련 반응

1건
반응 기록 만들기

화합물 노트

불러오는 중…